ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
I

SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patients With HER2+ Unresectable/mBC Previously Treated With T-DM1

By ecancer FEATURING Ian Krop
By ecancer FEATURING Ian Krop
99 views
January 10, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
SABCS 2022
06:32

SABCS 2022 Genomic Assay and Prediction of Long-Term Prognosis in Pr…

ecancer

R. O'Regan

175 views
04:05

SABCS 2022 Breast Cancer Patients and Interrupted ET to Pursue Pregn…

ecancer

C. Saura

96 views
03:24

SABCS 2022 EMERALD Phase 3 Trial: Elacestrant and PFS in ER+/HER2- m…

ecancer

V. Kaklamani

2.4K views
06:53

SABCS 2022 Primary Results From the POSITIVE Trial: Interruption of …

ecancer

A. Partridge

592 views
05:21

SABCS 2022 Follow-Up of Patients With Early BC After 30 Years: Radio…

ecancer

I. Kunkler

94 views
07:12

SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patient…

ecancer

I. Krop

99 views
11:02

SABCS 2022 Treatment Decision Guided by CTC Count and Long-Term Outc…

ecancer

J. Pierga

288 views
17:26

SABCS 2022 Updates From TAILORx and RxPONDER Trials: Implications fo…

ecancer

C. Markopoulos, K. Kalinsky

774 views